Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Que

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Journal of Cancer|July 12, 2019
Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patientsWei Xiao, Yao Liang, Yi Que, et al.
BMC Pediatrics|November 1, 2025
Pediatric NUT carcinoma: a patient series and literature reviewYalan You, Suying Lu, Feifei Sun, et al.
Oncotargets and Therapy|May 16, 2018
A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failureWei Xiao, Yi Que, Ruiqing Peng, et al.
The World Allergy Organization Journal|April 8, 2025
The novel house dust mite allergen Der p 39 exacerbates atopic dermatitis-like inflammation in mice by inducing skin barrier dysfunctionShan Liu, Ze-Lang Cai, Jingcheng Liu, et al.
Cancer Biology & Medicine|September 14, 2019
LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survivalYi Que, Zhixin Fang, Yuanxiang Guan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2023
Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint BlockadeDong-Chun Hong, Jing Yang, Cong Sun, et al.
Cancer|April 16, 2020
Chimeric antigen receptor-modified T-cell therapy for platelet-derived growth factor receptor α-positive rhabdomyosarcomaWei Xiao, Jinghua Wang, Xizhi Wen, et al.
Cancer Gene Therapy|August 25, 2024
FGFR4-specific CAR-T cells with inducible caspase-9 suicide gene as an approach to treat rhabdomyosarcomaWei Xiao, Liping Xu, Jinghua Wang, et al.
Therapeutic Advances in Medical Oncology|May 12, 2025
Characteristics, treatments, and outcomes of adolescents and adults with neuroblastoma: a retrospective study in ChinaWeiji Xie, Yu Zhang, Jiaqian Xu, et al.
NPJ Precision Oncology|May 18, 2026
Lorlatinib monotherapy or combination therapy in anaplastic lymphoma kinase-driven high-risk neuroblastomaWeiji Xie, Yu Zhang, Suying Lu, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cancer|July 12, 2019
Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patientsWei Xiao, Yao Liang, Yi Que, et al.
BMC Pediatrics|November 1, 2025
Pediatric NUT carcinoma: a patient series and literature reviewYalan You, Suying Lu, Feifei Sun, et al.
Oncotargets and Therapy|May 16, 2018
A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failureWei Xiao, Yi Que, Ruiqing Peng, et al.
The World Allergy Organization Journal|April 8, 2025
The novel house dust mite allergen Der p 39 exacerbates atopic dermatitis-like inflammation in mice by inducing skin barrier dysfunctionShan Liu, Ze-Lang Cai, Jingcheng Liu, et al.
Cancer Biology & Medicine|September 14, 2019
LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survivalYi Que, Zhixin Fang, Yuanxiang Guan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2023
Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint BlockadeDong-Chun Hong, Jing Yang, Cong Sun, et al.
Cancer|April 16, 2020
Chimeric antigen receptor-modified T-cell therapy for platelet-derived growth factor receptor α-positive rhabdomyosarcomaWei Xiao, Jinghua Wang, Xizhi Wen, et al.
Cancer Gene Therapy|August 25, 2024
FGFR4-specific CAR-T cells with inducible caspase-9 suicide gene as an approach to treat rhabdomyosarcomaWei Xiao, Liping Xu, Jinghua Wang, et al.
Therapeutic Advances in Medical Oncology|May 12, 2025
Characteristics, treatments, and outcomes of adolescents and adults with neuroblastoma: a retrospective study in ChinaWeiji Xie, Yu Zhang, Jiaqian Xu, et al.
NPJ Precision Oncology|May 18, 2026
Lorlatinib monotherapy or combination therapy in anaplastic lymphoma kinase-driven high-risk neuroblastomaWeiji Xie, Yu Zhang, Suying Lu, et al.
Pageof 6